auxilium pharmaceuticals inc
(AUXL:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)
As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).
Auxilium%20Pharmaceuticals%20Inc.%20%28NasdaqGS%3AAUXL%29%20acquired%20Actient%20Pharmaceuticals%2C%20LLC%20from%20GTCR%20Fund%20IX%2C%20L.P.%2C%20a%20fund%20of%20GTCR%2C%20LLC%20and%20other%20shareholders%20for%20approximately%20%24640%20million%20on%20April%2026%2C%202013.%20Auxilium%20paid%20%24585%20million%20in%20cash%20to%20Actient%20unit%20holders%2C%20a%20warrant%20for%201.25%20million%20shares%20of%20Auxilium%20common%20stock%20with%20an%20exercise%20price%20of%20%2417.80%20per%20share%20and%20up%20to%20%2450%20million%20of%20contingent%20consideration%20based%20upon%20the%20achievement%20of%20future%20revenue%20targets.%20Auxilium%20deposited%20%2425%20million%20in%20escrow%20account%20as%20a%20part%20of%20the%20%24585%20million%20consideration.%20The%20%2450%20million%20of%20earn-out%20payments%20will%20be%20payable%20in%20three%20stages.%20Firstly%20%2415%20million%20will%20be%20paid%20when%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20from%20and%20after%20the%20closing%20equal%20%24150%20million.%20Then%20%2410%20million%20will%20be%20payable%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twelve-month%20period%20commencing%20May%201%2C%202013%20exceed%20%24150%20million.%20Lastly%20%2425%20million%20will%20be%20paid%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twenty%20four%20month-period%20commencing%20May%201%2C%202013%20exceed%20%24300%20million.%0D%0A%0D%0AEach%20Actient%20option%20outstanding%20immediately%20prior%20to%20the%20merger%2C%20was%20cancelled%20and%20converted%20into%20the%20right%20to%20receive%2C%20without%20interest%2C%20an%20amount%20in%20cash%20equal%20to%20the%20pro%20rata%20portion%20of%20the%20transaction%20consideration%20attributable%20to%20each%20Actient%20unit%20less%20the%20per%20share%20exercise%20price%20of%20each%20such%20option.%20Auxilium%20used%20cash%20on%20hand%20and%20the%20proceeds%20from%20a%20new%20secured%20loan%20of%20%24225%20million%20from%20Morgan%20Stanley%20Senior%20Funding%2C%20Inc%20to%20finance%20the%20acquisition.%20The%20transaction%20is%20expected%20to%20be%20immediately%20accretive%20on%20a%20non-GAAP%20basis%20to%20Auxilium%27s%202013%20adjusted%20net%20income.%20The%20deal%20has%20been%20approved%20by%20the%20Board%20of%20Directors%20of%20Auxilium%20and%20Actient.%0D%0A%0D%0AMorgan%20Stanley%20and%20Centerview%20Partners%20acted%20as%20financial%20advisors%20to%20Auxilium.%20Morgan%2C%20Lewis%20%26%20Bockius%20LLP%20and%20Adam%20M.%20Turteltaub%20of%20Willkie%20Farr%20%26%20Gallagher%20LLP%20acted%20as%20legal%20advisors%20to%20Auxilium.%20Jefferies%20LLC%20acted%20as%20financial%20advisor%20to%20Actient.%20Hogan%20Lovells%20US%20LLP%20acted%20as%20legal%20advisor%20to%20Actient%20and%20GTCR%2C%20LLC.%20Sanford%20E.%20Perl%20and%20Michael%20H.%20Weed%2C%20Michael%20Snow%2C%20Hayley%20Smith%2C%20Anjna%20Mehta%2C%20Peter%20Stach%2C%20Dennis%20Myers%2C%20Jocelyn%20Hirsch%2C%20Dean%20Pettinga%2C%20Russell%20Light%2C%20Joel%20Peters-Fransen%2C%20Dean%20Bachus%2C%20Vladimir%20Khodosh%2C%20Michael%20Chen%2C%20Alexandra%20Mihalas%2C%20John%20Irving%2C%20Tim%20Stephenson%2C%20Brian%20Land%2C%20and%20John%20Caruso%20of%20Kirkland%20%26%20Ellis%20LLP%20acted%20as%20legal%20advisors%20to%20GTCR%2C%20LLC.%20Kellie%20Kennedy%20of%20The%20Harbinger%20Group%20acted%20as%20public%20relations%20advisor%20to%20Actient.%20Frank%20Aquila%2C%20Brian%20Hamilton%20and%20Marshall%20Yuan%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisor%20for%20Centerview%20Partners.
Auxilium%20Pharmaceuticals%20Inc.%20%28NasdaqGS%3AAUXL%29%20acquired%20Actient%20Pharmaceuticals%2C%20LLC%20from%20GTCR%20Fund%20IX%2C%20L.P.%2C%20a%20fund%20of%20GTCR%2C%20LLC%20and%20other%20shareholders%20for%20approximately%20%24640%20million%20on%20April%2026%2C%202013.%20Auxilium%20paid%20%24585%20million%20in%20cash%20to%20Actient%20unit%20holders%2C%20a%20warrant%20for%201.25%20million%20shares%20of%20Auxilium%20common%20stock%20with%20an%20exercise%20price%20of%20%2417.80%20per%20share%20and%20up%20to%20%2450%20million%20of%20contingent%20consideration%20based%20upon%20the%20achievement%20of%20future%20revenue%20targets.%20Auxilium%20deposited%20%2425%20million%20in%20escrow%20account%20as%20a%20part%20of%20the%20%24585%20million%20consideration.%20The%20%2450%20million%20of%20earn-out%20payments%20will%20be%20payable%20in%20three%20stages.%20Firstly%20%2415%20million%20will%20be%20paid%20when%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20from%20and%20after%20the%20closing%20equal%20%24150%20million.%20Then%20%2410%20million%20will%20be%20payable%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twelve-month%20period%20commencing%20May%201%2C%202013%20exceed%20%24150%20million.%20Lastly%20%2425%20million%20will%20be%20paid%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twenty%20four%20month-period%20commencing%20May%201%2C%202013%20exceed%20%24300%20million.%0D%0A%0D%0AEach%20Actient%20option%20outstanding%20immediately%20prior%20to%20the%20merger%2C%20was%20cancelled%20and%20converted%20into%20the%20right%20to%20receive%2C%20without%20interest%2C%20an%20amount%20in%20cash%20equal%20to%20the%20pro%20rata%20portion%20of%20the%20transaction%20consideration%20attributable%20to%20each%20Actient%20unit%20less%20the%20per%20share%20exercise%20price%20of%20each%20such%20option.%20Auxilium%20used%20cash%20on%20hand%20and%20the%20proceeds%20from%20a%20new%20secured%20loan%20of%20%24225%20million%20from%20Morgan%20Stanley%20Senior%20Funding%2C%20Inc%20to%20finance%20the%20acquisition.%20The%20transaction%20is%20expected%20to%20be%20immediately%20accretive%20on%20a%20non-GAAP%20basis%20to%20Auxilium%27s%202013%20adjusted%20net%20income.%20The%20deal%20has%20been%20approved%20by%20the%20Board%20of%20Directors%20of%20Auxilium%20and%20Actient.%0D%0A%0D%0AMorgan%20Stanley%20and%20Centerview%20Partners%20acted%20as%20financial%20advisors%20to%20Auxilium.%20Morgan%2C%20Lewis%20%26%20Bockius%20LLP%20and%20Adam%20M.%20Turteltaub%20of%20Willkie%20Farr%20%26%20Gallagher%20LLP%20acted%20as%20legal%20advisors%20to%20Auxilium.%20Jefferies%20LLC%20acted%20as%20financial%20advisor%20to%20Actient.%20Hogan%20Lovells%20US%20LLP%20acted%20as%20legal%20advisor%20to%20Actient%20and%20GTCR%2C%20LLC.%20Sanford%20E.%20Perl%20and%20Michael%20H.%20Weed%2C%20Michael%20Snow%2C%20Hayley%20Smith%2C%20Anjna%20Mehta%2C%20Peter%20Stach%2C%20Dennis%20Myers%2C%20Jocelyn%20Hirsch%2C%20Dean%20Pettinga%2C%20Russell%20Light%2C%20Joel%20Peters-Fransen%2C%20Dean%20Bachus%2C%20Vladimir%20Khodosh%2C%20Michael%20Chen%2C%20Alexandra%20Mihalas%2C%20John%20Irving%2C%20Tim%20Stephenson%2C%20Brian%20Land%2C%20and%20John%20Caruso%20of%20Kirkland%20%26%20Ellis%20LLP%20acted%20as%20legal%20advisors%20to%20GTCR%2C%20LLC.%20Kellie%20Kennedy%20of%20The%20Harbinger%20Group%20acted%20as%20public%20relations%20advisor%20to%20Actient.%20Frank%20Aquila%2C%20Brian%20Hamilton%20and%20Marshall%20Yuan%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisor%20for%20Centerview%20Partners.
Auxilium%20Pharmaceuticals%20Inc.%20%28NasdaqGS%3AAUXL%29%20acquired%20Actient%20Pharmaceuticals%2C%20LLC%20from%20GTCR%20Fund%20IX%2C%20L.P.%2C%20a%20fund%20of%20GTCR%2C%20LLC%20and%20other%20shareholders%20for%20approximately%20%24640%20million%20on%20April%2026%2C%202013.%20Auxilium%20paid%20%24585%20million%20in%20cash%20to%20Actient%20unit%20holders%2C%20a%20warrant%20for%201.25%20million%20shares%20of%20Auxilium%20common%20stock%20with%20an%20exercise%20price%20of%20%2417.80%20per%20share%20and%20up%20to%20%2450%20million%20of%20contingent%20consideration%20based%20upon%20the%20achievement%20of%20future%20revenue%20targets.%20Auxilium%20deposited%20%2425%20million%20in%20escrow%20account%20as%20a%20part%20of%20the%20%24585%20million%20consideration.%20The%20%2450%20million%20of%20earn-out%20payments%20will%20be%20payable%20in%20three%20stages.%20Firstly%20%2415%20million%20will%20be%20paid%20when%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20from%20and%20after%20the%20closing%20equal%20%24150%20million.%20Then%20%2410%20million%20will%20be%20payable%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twelve-month%20period%20commencing%20May%201%2C%202013%20exceed%20%24150%20million.%20Lastly%20%2425%20million%20will%20be%20paid%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twenty%20four%20month-period%20commencing%20May%201%2C%202013%20exceed%20%24300%20million.%0D%0A%0D%0AEach%20Actient%20option%20outstanding%20immediately%20prior%20to%20the%20merger%2C%20was%20cancelled%20and%20converted%20into%20the%20right%20to%20receive%2C%20without%20interest%2C%20an%20amount%20in%20cash%20equal%20to%20the%20pro%20rata%20portion%20of%20the%20transaction%20consideration%20attributable%20to%20each%20Actient%20unit%20less%20the%20per%20share%20exercise%20price%20of%20each%20such%20option.%20Auxilium%20used%20cash%20on%20hand%20and%20the%20proceeds%20from%20a%20new%20secured%20loan%20of%20%24225%20million%20from%20Morgan%20Stanley%20Senior%20Funding%2C%20Inc%20to%20finance%20the%20acquisition.%20The%20transaction%20is%20expected%20to%20be%20immediately%20accretive%20on%20a%20non-GAAP%20basis%20to%20Auxilium%27s%202013%20adjusted%20net%20income.%20The%20deal%20has%20been%20approved%20by%20the%20Board%20of%20Directors%20of%20Auxilium%20and%20Actient.%0D%0A%0D%0AMorgan%20Stanley%20and%20Centerview%20Partners%20acted%20as%20financial%20advisors%20to%20Auxilium.%20Morgan%2C%20Lewis%20%26%20Bockius%20LLP%20and%20Adam%20M.%20Turteltaub%20of%20Willkie%20Farr%20%26%20Gallagher%20LLP%20acted%20as%20legal%20advisors%20to%20Auxilium.%20Jefferies%20LLC%20acted%20as%20financial%20advisor%20to%20Actient.%20Hogan%20Lovells%20US%20LLP%20acted%20as%20legal%20advisor%20to%20Actient%20and%20GTCR%2C%20LLC.%20Sanford%20E.%20Perl%20and%20Michael%20H.%20Weed%2C%20Michael%20Snow%2C%20Hayley%20Smith%2C%20Anjna%20Mehta%2C%20Peter%20Stach%2C%20Dennis%20Myers%2C%20Jocelyn%20Hirsch%2C%20Dean%20Pettinga%2C%20Russell%20Light%2C%20Joel%20Peters-Fransen%2C%20Dean%20Bachus%2C%20Vladimir%20Khodosh%2C%20Michael%20Chen%2C%20Alexandra%20Mihalas%2C%20John%20Irving%2C%20Tim%20Stephenson%2C%20Brian%20Land%2C%20and%20John%20Caruso%20of%20Kirkland%20%26%20Ellis%20LLP%20acted%20as%20legal%20advisors%20to%20GTCR%2C%20LLC.%20Kellie%20Kennedy%20of%20The%20Harbinger%20Group%20acted%20as%20public%20relations%20advisor%20to%20Actient.%20Frank%20Aquila%2C%20Brian%20Hamilton%20and%20Marshall%20Yuan%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisor%20for%20Centerview%20Partners.
Auxilium%20Pharmaceuticals%20Inc.%20%28NasdaqGS%3AAUXL%29%20acquired%20Actient%20Pharmaceuticals%2C%20LLC%20from%20GTCR%20Fund%20IX%2C%20L.P.%2C%20a%20fund%20of%20GTCR%2C%20LLC%20and%20other%20shareholders%20for%20approximately%20%24640%20million%20on%20April%2026%2C%202013.%20Auxilium%20paid%20%24585%20million%20in%20cash%20to%20Actient%20unit%20holders%2C%20a%20warrant%20for%201.25%20million%20shares%20of%20Auxilium%20common%20stock%20with%20an%20exercise%20price%20of%20%2417.80%20per%20share%20and%20up%20to%20%2450%20million%20of%20contingent%20consideration%20based%20upon%20the%20achievement%20of%20future%20revenue%20targets.%20Auxilium%20deposited%20%2425%20million%20in%20escrow%20account%20as%20a%20part%20of%20the%20%24585%20million%20consideration.%20The%20%2450%20million%20of%20earn-out%20payments%20will%20be%20payable%20in%20three%20stages.%20Firstly%20%2415%20million%20will%20be%20paid%20when%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20from%20and%20after%20the%20closing%20equal%20%24150%20million.%20Then%20%2410%20million%20will%20be%20payable%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twelve-month%20period%20commencing%20May%201%2C%202013%20exceed%20%24150%20million.%20Lastly%20%2425%20million%20will%20be%20paid%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twenty%20four%20month-period%20commencing%20May%201%2C%202013%20exceed%20%24300%20million.%0D%0A%0D%0AEach%20Actient%20option%20outstanding%20immediately%20prior%20to%20the%20merger%2C%20was%20cancelled%20and%20converted%20into%20the%20right%20to%20receive%2C%20without%20interest%2C%20an%20amount%20in%20cash%20equal%20to%20the%20pro%20rata%20portion%20of%20the%20transaction%20consideration%20attributable%20to%20each%20Actient%20unit%20less%20the%20per%20share%20exercise%20price%20of%20each%20such%20option.%20Auxilium%20used%20cash%20on%20hand%20and%20the%20proceeds%20from%20a%20new%20secured%20loan%20of%20%24225%20million%20from%20Morgan%20Stanley%20Senior%20Funding%2C%20Inc%20to%20finance%20the%20acquisition.%20The%20transaction%20is%20expected%20to%20be%20immediately%20accretive%20on%20a%20non-GAAP%20basis%20to%20Auxilium%27s%202013%20adjusted%20net%20income.%20The%20deal%20has%20been%20approved%20by%20the%20Board%20of%20Directors%20of%20Auxilium%20and%20Actient.%0D%0A%0D%0AMorgan%20Stanley%20and%20Centerview%20Partners%20acted%20as%20financial%20advisors%20to%20Auxilium.%20Morgan%2C%20Lewis%20%26%20Bockius%20LLP%20and%20Adam%20M.%20Turteltaub%20of%20Willkie%20Farr%20%26%20Gallagher%20LLP%20acted%20as%20legal%20advisors%20to%20Auxilium.%20Jefferies%20LLC%20acted%20as%20financial%20advisor%20to%20Actient.%20Hogan%20Lovells%20US%20LLP%20acted%20as%20legal%20advisor%20to%20Actient%20and%20GTCR%2C%20LLC.%20Sanford%20E.%20Perl%20and%20Michael%20H.%20Weed%2C%20Michael%20Snow%2C%20Hayley%20Smith%2C%20Anjna%20Mehta%2C%20Peter%20Stach%2C%20Dennis%20Myers%2C%20Jocelyn%20Hirsch%2C%20Dean%20Pettinga%2C%20Russell%20Light%2C%20Joel%20Peters-Fransen%2C%20Dean%20Bachus%2C%20Vladimir%20Khodosh%2C%20Michael%20Chen%2C%20Alexandra%20Mihalas%2C%20John%20Irving%2C%20Tim%20Stephenson%2C%20Brian%20Land%2C%20and%20John%20Caruso%20of%20Kirkland%20%26%20Ellis%20LLP%20acted%20as%20legal%20advisors%20to%20GTCR%2C%20LLC.%20Kellie%20Kennedy%20of%20The%20Harbinger%20Group%20acted%20as%20public%20relations%20advisor%20to%20Actient.%20Frank%20Aquila%2C%20Brian%20Hamilton%20and%20Marshall%20Yuan%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisor%20for%20Centerview%20Partners.
Auxilium%20Pharmaceuticals%20Inc.%20%28NasdaqGS%3AAUXL%29%20acquired%20Actient%20Pharmaceuticals%2C%20LLC%20from%20GTCR%20Fund%20IX%2C%20L.P.%2C%20a%20fund%20of%20GTCR%2C%20LLC%20and%20other%20shareholders%20for%20approximately%20%24640%20million%20on%20April%2026%2C%202013.%20Auxilium%20paid%20%24585%20million%20in%20cash%20to%20Actient%20unit%20holders%2C%20a%20warrant%20for%201.25%20million%20shares%20of%20Auxilium%20common%20stock%20with%20an%20exercise%20price%20of%20%2417.80%20per%20share%20and%20up%20to%20%2450%20million%20of%20contingent%20consideration%20based%20upon%20the%20achievement%20of%20future%20revenue%20targets.%20Auxilium%20deposited%20%2425%20million%20in%20escrow%20account%20as%20a%20part%20of%20the%20%24585%20million%20consideration.%20The%20%2450%20million%20of%20earn-out%20payments%20will%20be%20payable%20in%20three%20stages.%20Firstly%20%2415%20million%20will%20be%20paid%20when%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20from%20and%20after%20the%20closing%20equal%20%24150%20million.%20Then%20%2410%20million%20will%20be%20payable%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twelve-month%20period%20commencing%20May%201%2C%202013%20exceed%20%24150%20million.%20Lastly%20%2425%20million%20will%20be%20paid%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twenty%20four%20month-period%20commencing%20May%201%2C%202013%20exceed%20%24300%20million.%0D%0A%0D%0AEach%20Actient%20option%20outstanding%20immediately%20prior%20to%20the%20merger%2C%20was%20cancelled%20and%20converted%20into%20the%20right%20to%20receive%2C%20without%20interest%2C%20an%20amount%20in%20cash%20equal%20to%20the%20pro%20rata%20portion%20of%20the%20transaction%20consideration%20attributable%20to%20each%20Actient%20unit%20less%20the%20per%20share%20exercise%20price%20of%20each%20such%20option.%20Auxilium%20used%20cash%20on%20hand%20and%20the%20proceeds%20from%20a%20new%20secured%20loan%20of%20%24225%20million%20from%20Morgan%20Stanley%20Senior%20Funding%2C%20Inc%20to%20finance%20the%20acquisition.%20The%20transaction%20is%20expected%20to%20be%20immediately%20accretive%20on%20a%20non-GAAP%20basis%20to%20Auxilium%27s%202013%20adjusted%20net%20income.%20The%20deal%20has%20been%20approved%20by%20the%20Board%20of%20Directors%20of%20Auxilium%20and%20Actient.%0D%0A%0D%0AMorgan%20Stanley%20and%20Centerview%20Partners%20acted%20as%20financial%20advisors%20to%20Auxilium.%20Morgan%2C%20Lewis%20%26%20Bockius%20LLP%20and%20Adam%20M.%20Turteltaub%20of%20Willkie%20Farr%20%26%20Gallagher%20LLP%20acted%20as%20legal%20advisors%20to%20Auxilium.%20Jefferies%20LLC%20acted%20as%20financial%20advisor%20to%20Actient.%20Hogan%20Lovells%20US%20LLP%20acted%20as%20legal%20advisor%20to%20Actient%20and%20GTCR%2C%20LLC.%20Sanford%20E.%20Perl%20and%20Michael%20H.%20Weed%2C%20Michael%20Snow%2C%20Hayley%20Smith%2C%20Anjna%20Mehta%2C%20Peter%20Stach%2C%20Dennis%20Myers%2C%20Jocelyn%20Hirsch%2C%20Dean%20Pettinga%2C%20Russell%20Light%2C%20Joel%20Peters-Fransen%2C%20Dean%20Bachus%2C%20Vladimir%20Khodosh%2C%20Michael%20Chen%2C%20Alexandra%20Mihalas%2C%20John%20Irving%2C%20Tim%20Stephenson%2C%20Brian%20Land%2C%20and%20John%20Caruso%20of%20Kirkland%20%26%20Ellis%20LLP%20acted%20as%20legal%20advisors%20to%20GTCR%2C%20LLC.%20Kellie%20Kennedy%20of%20The%20Harbinger%20Group%20acted%20as%20public%20relations%20advisor%20to%20Actient.%20Frank%20Aquila%2C%20Brian%20Hamilton%20and%20Marshall%20Yuan%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisor%20for%20Centerview%20Partners.
Auxilium%20Pharmaceuticals%20Inc.%20%28NasdaqGS%3AAUXL%29%20acquired%20Actient%20Pharmaceuticals%2C%20LLC%20from%20GTCR%20Fund%20IX%2C%20L.P.%2C%20a%20fund%20of%20GTCR%2C%20LLC%20and%20other%20shareholders%20for%20approximately%20%24640%20million%20on%20April%2026%2C%202013.%20Auxilium%20paid%20%24585%20million%20in%20cash%20to%20Actient%20unit%20holders%2C%20a%20warrant%20for%201.25%20million%20shares%20of%20Auxilium%20common%20stock%20with%20an%20exercise%20price%20of%20%2417.80%20per%20share%20and%20up%20to%20%2450%20million%20of%20contingent%20consideration%20based%20upon%20the%20achievement%20of%20future%20revenue%20targets.%20Auxilium%20deposited%20%2425%20million%20in%20escrow%20account%20as%20a%20part%20of%20the%20%24585%20million%20consideration.%20The%20%2450%20million%20of%20earn-out%20payments%20will%20be%20payable%20in%20three%20stages.%20Firstly%20%2415%20million%20will%20be%20paid%20when%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20from%20and%20after%20the%20closing%20equal%20%24150%20million.%20Then%20%2410%20million%20will%20be%20payable%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twelve-month%20period%20commencing%20May%201%2C%202013%20exceed%20%24150%20million.%20Lastly%20%2425%20million%20will%20be%20paid%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twenty%20four%20month-period%20commencing%20May%201%2C%202013%20exceed%20%24300%20million.%0D%0A%0D%0AEach%20Actient%20option%20outstanding%20immediately%20prior%20to%20the%20merger%2C%20was%20cancelled%20and%20converted%20into%20the%20right%20to%20receive%2C%20without%20interest%2C%20an%20amount%20in%20cash%20equal%20to%20the%20pro%20rata%20portion%20of%20the%20transaction%20consideration%20attributable%20to%20each%20Actient%20unit%20less%20the%20per%20share%20exercise%20price%20of%20each%20such%20option.%20Auxilium%20used%20cash%20on%20hand%20and%20the%20proceeds%20from%20a%20new%20secured%20loan%20of%20%24225%20million%20from%20Morgan%20Stanley%20Senior%20Funding%2C%20Inc%20to%20finance%20the%20acquisition.%20The%20transaction%20is%20expected%20to%20be%20immediately%20accretive%20on%20a%20non-GAAP%20basis%20to%20Auxilium%27s%202013%20adjusted%20net%20income.%20The%20deal%20has%20been%20approved%20by%20the%20Board%20of%20Directors%20of%20Auxilium%20and%20Actient.%0D%0A%0D%0AMorgan%20Stanley%20and%20Centerview%20Partners%20acted%20as%20financial%20advisors%20to%20Auxilium.%20Morgan%2C%20Lewis%20%26%20Bockius%20LLP%20and%20Adam%20M.%20Turteltaub%20of%20Willkie%20Farr%20%26%20Gallagher%20LLP%20acted%20as%20legal%20advisors%20to%20Auxilium.%20Jefferies%20LLC%20acted%20as%20financial%20advisor%20to%20Actient.%20Hogan%20Lovells%20US%20LLP%20acted%20as%20legal%20advisor%20to%20Actient%20and%20GTCR%2C%20LLC.%20Sanford%20E.%20Perl%20and%20Michael%20H.%20Weed%2C%20Michael%20Snow%2C%20Hayley%20Smith%2C%20Anjna%20Mehta%2C%20Peter%20Stach%2C%20Dennis%20Myers%2C%20Jocelyn%20Hirsch%2C%20Dean%20Pettinga%2C%20Russell%20Light%2C%20Joel%20Peters-Fransen%2C%20Dean%20Bachus%2C%20Vladimir%20Khodosh%2C%20Michael%20Chen%2C%20Alexandra%20Mihalas%2C%20John%20Irving%2C%20Tim%20Stephenson%2C%20Brian%20Land%2C%20and%20John%20Caruso%20of%20Kirkland%20%26%20Ellis%20LLP%20acted%20as%20legal%20advisors%20to%20GTCR%2C%20LLC.%20Kellie%20Kennedy%20of%20The%20Harbinger%20Group%20acted%20as%20public%20relations%20advisor%20to%20Actient.%20Frank%20Aquila%2C%20Brian%20Hamilton%20and%20Marshall%20Yuan%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisor%20for%20Centerview%20Partners.
Auxilium%20Pharmaceuticals%20Inc.%20%28NasdaqGS%3AAUXL%29%20acquired%20Actient%20Pharmaceuticals%2C%20LLC%20from%20GTCR%20Fund%20IX%2C%20L.P.%2C%20a%20fund%20of%20GTCR%2C%20LLC%20and%20other%20shareholders%20for%20approximately%20%24640%20million%20on%20April%2026%2C%202013.%20Auxilium%20paid%20%24585%20million%20in%20cash%20to%20Actient%20unit%20holders%2C%20a%20warrant%20for%201.25%20million%20shares%20of%20Auxilium%20common%20stock%20with%20an%20exercise%20price%20of%20%2417.80%20per%20share%20and%20up%20to%20%2450%20million%20of%20contingent%20consideration%20based%20upon%20the%20achievement%20of%20future%20revenue%20targets.%20Auxilium%20deposited%20%2425%20million%20in%20escrow%20account%20as%20a%20part%20of%20the%20%24585%20million%20consideration.%20The%20%2450%20million%20of%20earn-out%20payments%20will%20be%20payable%20in%20three%20stages.%20Firstly%20%2415%20million%20will%20be%20paid%20when%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20from%20and%20after%20the%20closing%20equal%20%24150%20million.%20Then%20%2410%20million%20will%20be%20payable%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twelve-month%20period%20commencing%20May%201%2C%202013%20exceed%20%24150%20million.%20Lastly%20%2425%20million%20will%20be%20paid%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twenty%20four%20month-period%20commencing%20May%201%2C%202013%20exceed%20%24300%20million.%0D%0A%0D%0AEach%20Actient%20option%20outstanding%20immediately%20prior%20to%20the%20merger%2C%20was%20cancelled%20and%20converted%20into%20the%20right%20to%20receive%2C%20without%20interest%2C%20an%20amount%20in%20cash%20equal%20to%20the%20pro%20rata%20portion%20of%20the%20transaction%20consideration%20attributable%20to%20each%20Actient%20unit%20less%20the%20per%20share%20exercise%20price%20of%20each%20such%20option.%20Auxilium%20used%20cash%20on%20hand%20and%20the%20proceeds%20from%20a%20new%20secured%20loan%20of%20%24225%20million%20from%20Morgan%20Stanley%20Senior%20Funding%2C%20Inc%20to%20finance%20the%20acquisition.%20The%20transaction%20is%20expected%20to%20be%20immediately%20accretive%20on%20a%20non-GAAP%20basis%20to%20Auxilium%27s%202013%20adjusted%20net%20income.%20The%20deal%20has%20been%20approved%20by%20the%20Board%20of%20Directors%20of%20Auxilium%20and%20Actient.%0D%0A%0D%0AMorgan%20Stanley%20and%20Centerview%20Partners%20acted%20as%20financial%20advisors%20to%20Auxilium.%20Morgan%2C%20Lewis%20%26%20Bockius%20LLP%20and%20Adam%20M.%20Turteltaub%20of%20Willkie%20Farr%20%26%20Gallagher%20LLP%20acted%20as%20legal%20advisors%20to%20Auxilium.%20Jefferies%20LLC%20acted%20as%20financial%20advisor%20to%20Actient.%20Hogan%20Lovells%20US%20LLP%20acted%20as%20legal%20advisor%20to%20Actient%20and%20GTCR%2C%20LLC.%20Sanford%20E.%20Perl%20and%20Michael%20H.%20Weed%2C%20Michael%20Snow%2C%20Hayley%20Smith%2C%20Anjna%20Mehta%2C%20Peter%20Stach%2C%20Dennis%20Myers%2C%20Jocelyn%20Hirsch%2C%20Dean%20Pettinga%2C%20Russell%20Light%2C%20Joel%20Peters-Fransen%2C%20Dean%20Bachus%2C%20Vladimir%20Khodosh%2C%20Michael%20Chen%2C%20Alexandra%20Mihalas%2C%20John%20Irving%2C%20Tim%20Stephenson%2C%20Brian%20Land%2C%20and%20John%20Caruso%20of%20Kirkland%20%26%20Ellis%20LLP%20acted%20as%20legal%20advisors%20to%20GTCR%2C%20LLC.%20Kellie%20Kennedy%20of%20The%20Harbinger%20Group%20acted%20as%20public%20relations%20advisor%20to%20Actient.%20Frank%20Aquila%2C%20Brian%20Hamilton%20and%20Marshall%20Yuan%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisor%20for%20Centerview%20Partners.
Auxilium%20Pharmaceuticals%20Inc.%20%28NasdaqGS%3AAUXL%29%20acquired%20Actient%20Pharmaceuticals%2C%20LLC%20from%20GTCR%20Fund%20IX%2C%20L.P.%2C%20a%20fund%20of%20GTCR%2C%20LLC%20and%20other%20shareholders%20for%20approximately%20%24640%20million%20on%20April%2026%2C%202013.%20Auxilium%20paid%20%24585%20million%20in%20cash%20to%20Actient%20unit%20holders%2C%20a%20warrant%20for%201.25%20million%20shares%20of%20Auxilium%20common%20stock%20with%20an%20exercise%20price%20of%20%2417.80%20per%20share%20and%20up%20to%20%2450%20million%20of%20contingent%20consideration%20based%20upon%20the%20achievement%20of%20future%20revenue%20targets.%20Auxilium%20deposited%20%2425%20million%20in%20escrow%20account%20as%20a%20part%20of%20the%20%24585%20million%20consideration.%20The%20%2450%20million%20of%20earn-out%20payments%20will%20be%20payable%20in%20three%20stages.%20Firstly%20%2415%20million%20will%20be%20paid%20when%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20from%20and%20after%20the%20closing%20equal%20%24150%20million.%20Then%20%2410%20million%20will%20be%20payable%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twelve-month%20period%20commencing%20May%201%2C%202013%20exceed%20%24150%20million.%20Lastly%20%2425%20million%20will%20be%20paid%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twenty%20four%20month-period%20commencing%20May%201%2C%202013%20exceed%20%24300%20million.%0D%0A%0D%0AEach%20Actient%20option%20outstanding%20immediately%20prior%20to%20the%20merger%2C%20was%20cancelled%20and%20converted%20into%20the%20right%20to%20receive%2C%20without%20interest%2C%20an%20amount%20in%20cash%20equal%20to%20the%20pro%20rata%20portion%20of%20the%20transaction%20consideration%20attributable%20to%20each%20Actient%20unit%20less%20the%20per%20share%20exercise%20price%20of%20each%20such%20option.%20Auxilium%20used%20cash%20on%20hand%20and%20the%20proceeds%20from%20a%20new%20secured%20loan%20of%20%24225%20million%20from%20Morgan%20Stanley%20Senior%20Funding%2C%20Inc%20to%20finance%20the%20acquisition.%20The%20transaction%20is%20expected%20to%20be%20immediately%20accretive%20on%20a%20non-GAAP%20basis%20to%20Auxilium%27s%202013%20adjusted%20net%20income.%20The%20deal%20has%20been%20approved%20by%20the%20Board%20of%20Directors%20of%20Auxilium%20and%20Actient.%0D%0A%0D%0AMorgan%20Stanley%20and%20Centerview%20Partners%20acted%20as%20financial%20advisors%20to%20Auxilium.%20Morgan%2C%20Lewis%20%26%20Bockius%20LLP%20and%20Adam%20M.%20Turteltaub%20of%20Willkie%20Farr%20%26%20Gallagher%20LLP%20acted%20as%20legal%20advisors%20to%20Auxilium.%20Jefferies%20LLC%20acted%20as%20financial%20advisor%20to%20Actient.%20Hogan%20Lovells%20US%20LLP%20acted%20as%20legal%20advisor%20to%20Actient%20and%20GTCR%2C%20LLC.%20Sanford%20E.%20Perl%20and%20Michael%20H.%20Weed%2C%20Michael%20Snow%2C%20Hayley%20Smith%2C%20Anjna%20Mehta%2C%20Peter%20Stach%2C%20Dennis%20Myers%2C%20Jocelyn%20Hirsch%2C%20Dean%20Pettinga%2C%20Russell%20Light%2C%20Joel%20Peters-Fransen%2C%20Dean%20Bachus%2C%20Vladimir%20Khodosh%2C%20Michael%20Chen%2C%20Alexandra%20Mihalas%2C%20John%20Irving%2C%20Tim%20Stephenson%2C%20Brian%20Land%2C%20and%20John%20Caruso%20of%20Kirkland%20%26%20Ellis%20LLP%20acted%20as%20legal%20advisors%20to%20GTCR%2C%20LLC.%20Kellie%20Kennedy%20of%20The%20Harbinger%20Group%20acted%20as%20public%20relations%20advisor%20to%20Actient.%20Frank%20Aquila%2C%20Brian%20Hamilton%20and%20Marshall%20Yuan%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisor%20for%20Centerview%20Partners.
Auxilium%20Pharmaceuticals%20Inc.%20%28NasdaqGS%3AAUXL%29%20acquired%20Actient%20Pharmaceuticals%2C%20LLC%20from%20GTCR%20Fund%20IX%2C%20L.P.%2C%20a%20fund%20of%20GTCR%2C%20LLC%20and%20other%20shareholders%20for%20approximately%20%24640%20million%20on%20April%2026%2C%202013.%20Auxilium%20paid%20%24585%20million%20in%20cash%20to%20Actient%20unit%20holders%2C%20a%20warrant%20for%201.25%20million%20shares%20of%20Auxilium%20common%20stock%20with%20an%20exercise%20price%20of%20%2417.80%20per%20share%20and%20up%20to%20%2450%20million%20of%20contingent%20consideration%20based%20upon%20the%20achievement%20of%20future%20revenue%20targets.%20Auxilium%20deposited%20%2425%20million%20in%20escrow%20account%20as%20a%20part%20of%20the%20%24585%20million%20consideration.%20The%20%2450%20million%20of%20earn-out%20payments%20will%20be%20payable%20in%20three%20stages.%20Firstly%20%2415%20million%20will%20be%20paid%20when%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20from%20and%20after%20the%20closing%20equal%20%24150%20million.%20Then%20%2410%20million%20will%20be%20payable%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twelve-month%20period%20commencing%20May%201%2C%202013%20exceed%20%24150%20million.%20Lastly%20%2425%20million%20will%20be%20paid%20if%20cumulative%20net%20sales%20of%20Actient%u2019s%20urology%20products%20during%20the%20twenty%20four%20month-period%20commencing%20May%201%2C%202013%20exceed%20%24300%20million.%0D%0A%0D%0AEach%20Actient%20option%20outstanding%20immediately%20prior%20to%20the%20merger%2C%20was%20cancelled%20and%20converted%20into%20the%20right%20to%20receive%2C%20without%20interest%2C%20an%20amount%20in%20cash%20equal%20to%20the%20pro%20rata%20portion%20of%20the%20transaction%20consideration%20attributable%20to%20each%20Actient%20unit%20less%20the%20per%20share%20exercise%20price%20of%20each%20such%20option.%20Auxilium%20used%20cash%20on%20hand%20and%20the%20proceeds%20from%20a%20new%20secured%20loan%20of%20%24225%20million%20from%20Morgan%20Stanley%20Senior%20Funding%2C%20Inc%20to%20finance%20the%20acquisition.%20The%20transaction%20is%20expected%20to%20be%20immediately%20accretive%20on%20a%20non-GAAP%20basis%20to%20Auxilium%27s%202013%20adjusted%20net%20income.%20The%20deal%20has%20been%20approved%20by%20the%20Board%20of%20Directors%20of%20Auxilium%20and%20Actient.%0D%0A%0D%0AMorgan%20Stanley%20and%20Centerview%20Partners%20acted%20as%20financial%20advisors%20to%20Auxilium.%20Morgan%2C%20Lewis%20%26%20Bockius%20LLP%20and%20Adam%20M.%20Turteltaub%20of%20Willkie%20Farr%20%26%20Gallagher%20LLP%20acted%20as%20legal%20advisors%20to%20Auxilium.%20Jefferies%20LLC%20acted%20as%20financial%20advisor%20to%20Actient.%20Hogan%20Lovells%20US%20LLP%20acted%20as%20legal%20advisor%20to%20Actient%20and%20GTCR%2C%20LLC.%20Sanford%20E.%20Perl%20and%20Michael%20H.%20Weed%2C%20Michael%20Snow%2C%20Hayley%20Smith%2C%20Anjna%20Mehta%2C%20Peter%20Stach%2C%20Dennis%20Myers%2C%20Jocelyn%20Hirsch%2C%20Dean%20Pettinga%2C%20Russell%20Light%2C%20Joel%20Peters-Fransen%2C%20Dean%20Bachus%2C%20Vladimir%20Khodosh%2C%20Michael%20Chen%2C%20Alexandra%20Mihalas%2C%20John%20Irving%2C%20Tim%20Stephenson%2C%20Brian%20Land%2C%20and%20John%20Caruso%20of%20Kirkland%20%26%20Ellis%20LLP%20acted%20as%20legal%20advisors%20to%20GTCR%2C%20LLC.%20Kellie%20Kennedy%20of%20The%20Harbinger%20Group%20acted%20as%20public%20relations%20advisor%20to%20Actient.%20Frank%20Aquila%2C%20Brian%20Hamilton%20and%20Marshall%20Yuan%20of%20Sullivan%20%26%20Cromwell%20LLP%20acted%20as%20legal%20advisor%20for%20Centerview%20Partners.
To
mm/dd/yyyy
mm/dd/yyyy
From
mm/dd/yyyy
mm/dd/yyyyDate Range for Stats (05/19/2013 to 05/19/2013)
|
-- High-- Low## % Change |
0 Number of Dividends Paid-- Average Dividend Paid$0.00 Dividends Paid Per Period |
0 Splits9 Transactions365 Days In Range |
Select View:
Open, High, Low, and Close are split adjusted. Adjusted close reflects dividend payouts.
Stock Quotes
Market data is delayed at least 15 minutes.
| Recently Viewed | |||
| AUXL:US | $15.01 USD | -0.04 |  |
COMPETITOR HISTORICAL STOCK QUOTES
| Company | % Change | ||
| Acrux Ltd | -- | A$3.87 AUD | -- |
| Actavis Inc | -- | $125.50 USD | -- |
| Antares Pharma I... | -- | $4.06 USD | -- |
| Mylan Inc/PA | -- | $31.40 USD | -- |
| Teva Pharmaceuti... | -- | $40.23 USD | -- |
| View Industry Companies | |||
Day VS. Day Stock Price Comparison
| Open | ||
| High | ||
| Low | ||
| Close | ||
| Volume |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact AUXILIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
